Lyophilized Products Are On The Rise: What You Need To Know
![GettyImages-1316775813-vial-production GettyImages-1316775813-vial-production](https://vertassets.blob.core.windows.net/image/0e7b30a6/0e7b30a6-58eb-496d-b4a6-afd364a0cc9a/375_250-gettyimages_1316775813_vial_production.jpg)
When Spine BioPharma was looking for support in redeveloping and manufacturing a drug product recently, they found a partner in Emergent BioSolutions. As a contract development manufacturing organization (CDMO), Emergent would be able to quickly ramp up production of the drug at hand, and it would also be able to convert it to a form that would make it stable at room temperature, through a process called lyophilization. That process—also known as freeze-drying—would, in turn, simplify logistics for shipping and storage.
Spine BioPharma is just one of many biopharmaceutical organizations seeking assistance in the lyophilization process, which is growing in popularity. According to a report by MarketsandMarkets, the global freeze-drying/lyophilization equipment market is expected to reach $7.3 billion by 2025—from $4.9 billion in 2020—at a CAGR of 8.2%.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.